Irinotecan/cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancer.

Oncology (Williston Park, N.Y.)

Volumn 17, Issue 9 Suppl 8, 2003, Pages 20-22

  Ajani, Jaffer A ^a   Faust, Josephine ^a   Yao, James ^a   Komaki, Ritsuko ^a   Stevens, Craig ^a   Swisher, Stephen ^a   Putnam, Joe B ^a   Vaporciyan, Ara ^a   Smythe, Roy ^a   Walsh, Garrett ^a   Rice, David ^a   Roth, Jack ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CISPLATIN; DRUG DERIVATIVE; FLUOROURACIL; IRINOTECAN; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG ADMINISTRATION; ESOPHAGUS TUMOR; FEMALE; HUMAN; MALE; MIDDLE AGED;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; RADIOTHERAPY, ADJUVANT;

EID: 1542465989     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)